← Back to NXTC

NextCure, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 18/08/2026Mar 2026Filed 18/08/2026Sep 2025Filed 05/11/2025Jun 2025Filed 18/08/2026Mar 2025Filed 18/08/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/11/2025Mar 2024Filed 05/11/2025
−$15−$9.8−$8.6−$27−$11−$12−$15−$17
−$2.80−$1.87−$3.22−$11.29−$4.70−$4.95−$6.61−$0.61
5.35.22.72.42.32.32.328

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.